{"id":"W2162105656","doi":"10.1002/ibd.21117","title":"Teduglutide, a novel mucosally active analog of glucagon-like peptide-2 (GLP-2) for the treatment of moderate to severe Crohnʼs disease","year":2009,"lang":"en","type":"article","venue":"Inflammatory Bowel Diseases","topic":"Inflammatory Bowel Disease","field":"Biochemistry, Genetics and Molecular Biology","cited_by":143,"is_retracted":false,"has_abstract":true,"ca_institutions":"University of Manitoba","funders":"","keywords":"Medicine; Placebo; Gastroenterology; Internal medicine; Crohn's disease; Clinical endpoint; Placebo-controlled study; Glucagon-like peptide-2; Randomized controlled trial; Disease; Double blind; Peptide; Pathology","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0005638669,0.0003192709,0.0009708655,0.0002264186,0.0001415195,0.0002415405,0.0003340639,0.0003986069,0.001178827],"category_scores_gemma":[0.0003966501,0.00015086,0.0003454076,0.0001757808,0.0003733031,0.0002074762,0.0001547246,0.0005629755,0.0001936628],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0001673957,"about_ca_system_score_gemma":0.0002904454,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002065373,"about_ca_topic_score_gemma":0.0006876427,"domain_scores_codex":[0.9998815,0.00005121252,0.00001862512,0.00001836136,0.00001416028,0.000016105],"domain_scores_gemma":[0.9998164,0.00004211308,0.0000560814,0.000007776034,0.00001074426,0.00006697172],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"bench_or_experimental","study_design_scores_codex":[0.3963059,0.01912936,0.01474617,0.004627785,0.001020966,0.001287922,0.0002414111,0.001010807,0.2127756,0.0003367376,0.002946993,0.3455703],"study_design_scores_gemma":[0.2893973,0.5869244,0.07376316,0.0003198069,0.001631537,0.003191676,0.0001537625,0.001630494,0.02688596,0.0002076726,0.01579974,0.0000944216],"study_design_candidate":"bench_or_experimental","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9848306,0.01263672,0.0007704474,0.0002390988,0.0001280966,0.0004872703,0.0001936937,0.00005840817,0.0006557105],"genre_scores_gemma":[0.9902022,0.005985746,0.001893957,0.0004520215,0.0001488553,0.0004004563,0.0003315002,0.000004761766,0.0005805106],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001178827,"threshold_uncertainty_score":0.003943563,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01091762890596418,"score_gpt":0.2520489248887559,"score_spread":0.2411312959827917,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}